Bibliografías temáticas / Crigler-Najjar / Artículos de revistas

Artículos de revistas sobre el tema "Crigler-Najjar"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Crigler-Najjar.
Autor: Grafiati
Publicado: 11 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Crigler-Najjar".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Haque, Md Azizul, Laila Shamima Sharmin, Mohd Harun or Rashid, MA Alim, ARM Saifuddin Ekram y Syed Ghulam Mogni Mowla. "Crigler-Najjar Syndrome Type 2 in a Young Adult". Journal of Medicine 12, n.º 1 (21 de enero de 2011): 86–88. http://dx.doi.org/10.3329/jom.v12i1.6359.

Texto completo
Resumen
Crigler-Najjar syndrome type 2 in an autosomal recessive congenital non-hemolytic hyperbilirubinemia caused by UDP-glucuronosyltransferase deficiency. Only a few hundred cases have been described in the literature so far. We are reporting Crigler-Najjar syndrome type 2 in an 18 year old female born out of consanguineous marriage. Keyword: Crigler-Najjar syndrome; UDP-glucuronosyltransferase; Bangladesh DOI: 10.3329/jom.v12i1.6359J Medicine 2011; 12 : 81-85
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Fatima, Bushra, Ayesha Ahmad, Tamkin Khan y Rizwan Ahmad. "Crigler Najjar Syndrome [Type II] with Pregnancy: Case Report". International Journal of Human and Health Sciences (IJHHS) 4, n.º 1 (31 de octubre de 2019): 60. http://dx.doi.org/10.31344/ijhhs.v4i1.121.

Texto completo
Resumen
Crigler-Najjar syndromes are rare, autosomal recessive disorders caused by mutations in the genes of bilirubin metabolism. The management of these pregnancies is controversial due to paucity of literature. We discuss here a successfully managed case of pregnancy with Crigler-Najjar Syndrome.International Journal of Human and Health Sciences Vol. 04 No. 01 January’20 Page : 60-62
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Radlovic, Nedeljko. "Hereditary hyperbilirubinemias". Srpski arhiv za celokupno lekarstvo 142, n.º 3-4 (2014): 257–60. http://dx.doi.org/10.2298/sarh1404257r.

Texto completo
Resumen
Inherited disorders of bilirubin metabolism involve four autosomal recessive syndromes: Gilbert, Crigler- Najjar, Dubin-Johnson and Rotor, among which the first two are characterized by unconjugated and the second two by conjugated hyperbilirubinemia. Gilbert syndrome occurs in 2%-10% of general population, while others are rare. Except for Crigler-Najjar syndrome, hereditary hyperbilirubinemias belong to benign disorders and thus no treatment is required.
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Torres, M. y M. Bruguera. "Síndrome de Crigler-Najjar". Gastroenterología y Hepatología 28, n.º 10 (diciembre de 2005): 637–40. http://dx.doi.org/10.1016/s0210-5705(05)71530-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

RUBALTELLI, FIRMINO F., PIETRO GUERRINI, ELENA REDDI y GIULIO JORI. "Tin-Protoporphyrin in the Management of Children With Crigler-Najjar Disease". Pediatrics 84, n.º 4 (1 de octubre de 1989): 728–31. http://dx.doi.org/10.1542/peds.84.4.728.

Texto completo
Resumen
The Crigler-Najjar disease is a rare disorder originally described in 1952 and characterized by a severe unconjugated hyperbilirubinemia appearing in the first days of life and persisting throughout life. In 1969, Arias et al proposed to subdivide such patients into two groups. The first group (Crigler-Najjar disease type 1) consisted of the most severely jaundiced infants in whom bilirubin encephalopathy developed resulting in death, usually within the first year of life, and whose plasma bilirubin level did not decrease during treatment with phenobarbital. Their bile was described as virtually colorless and appeared to contain only a trace amount of bilirubin, all in the unconjugated form. In the second group (Crigler-Najjar disease type 2), bilirubin conjugates were detected in normally yellow bile. In these patients, the unconjugated hyperbilirubinemia was less severe and encephalopathy was absent.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Šelih, Anja y Manca Velkavrh. "CRIGLER- NAJJAR SYNDROME – CASE REPORT". Slovenska pediatrija, revija pediatrov Slovenije in specialistov šolske ter visokošolske medicine Slovenije 29, n.º 2 (2022): 78–82. http://dx.doi.org/10.38031/slovpediatr-2022-2-04en.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Huang, Ching-Shan, Nancy Tan, Sien-Sing Yang, Yung-Chan Sung y May-Jen Huang. "Crigler-Najjar Syndrome Type 2". Journal of the Formosan Medical Association 105, n.º 11 (2006): 950–53. http://dx.doi.org/10.1016/s0929-6646(09)60182-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Güldütuna, Sükrettin, Ulrich Langenbeck, Karl Walter Bock, Andreas Sieg y Ulrich Leuschner. "Crigler-Najjar syndrome type II". Digestive Diseases and Sciences 40, n.º 1 (enero de 1995): 28–32. http://dx.doi.org/10.1007/bf02063937.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

MCDONAGH, ANTONY F. "Tin-protoporphyrin in the Management of Children With Crigler-Najjar Disease". Pediatrics 86, n.º 1 (1 de julio de 1990): 151–52. http://dx.doi.org/10.1542/peds.86.1.151a.

Texto completo
Resumen
To the Editor.— Rubaltelli et al1 recently described the use of tin-protoporphyrin (SnPp) to block bilirubin formation in a child with the potentially fatal Crigler-Najjar Type II disease, a genetic disorder characterized by an inability to conjugate and excrete bilirubin in the normal way. Although repeated administration of SnPp failed to suppress the plasma bilirubin concentration significantly in their patient, perhaps because of the buffering effect of a relatively large extravascular pool of bilirubin, it did appear to diminish the need for phototherapy, suggesting that SnPp might be a useful adjuvant to phototherapy in the treatment of Crigler-Najjar disease.
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Cahill, D. J. y C. F. McCarthy. "Pregnancy and the Crigler-Najjar syndrome". Journal of Obstetrics and Gynaecology 9, n.º 3 (enero de 1989): 213. http://dx.doi.org/10.3109/01443618909151039.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Weiß, Johannes. "Orphan Disease – Das Crigler-Najjar Syndrom". Zeitschrift für Gastroenterologie 52, n.º 04 (15 de abril de 2014): 338. http://dx.doi.org/10.1055/s-0033-1362434.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Alaman, Alizah, Munira Minaz Ali, Nazish Hussain Ali Pachani y Anmol Minaz Ali. "Crigler-Najjar Syndrome: A Rare Fatality". International Journal of Women Empowerment 2, n.º 1 (1 de diciembre de 2016): 22. http://dx.doi.org/10.29052/2413-4252.v2.i1.2016.22-30.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Bhalchandra Deore, Amol. "Crigler najjar syndrome: A systematic outline". Indian Journal of Pharmacy and Pharmacology 6, n.º 3 (15 de octubre de 2019): 75–78. http://dx.doi.org/10.18231/j.ijpp.2019.017.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Nazer, Hisham, Ali Al-Mehaidib, Souheil Shabib y M. Ashraf Ali. "Crigler-Najjar syndrome in Saudi Arabia". American Journal of Medical Genetics 79, n.º 1 (27 de agosto de 1998): 12–15. http://dx.doi.org/10.1002/(sici)1096-8628(19980827)79:1<12::aid-ajmg4>3.0.co;2-k.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Ilchenko, L. Yu, I. G. Fedorov, G. G. Totolyan, A. G. Tsvetkova, E. G. Gavrilenko, K. O. Mironov y I. G. Nikitin. "HEREDITARY UNCONJUGATED HYPERBILIRUBINEMIA (COMBINATION OF CRIGLER-NAJJAR SYNDROME TYPE II AND GILBERT'S SYNDROME)". Hepatology and Gastroenterology 5, n.º 1 (10 de junio de 2021): 79–84. http://dx.doi.org/10.25298/2616-5546-2021-5-1-79-84.

Texto completo
Resumen
Background. Enzymopathic jaundices are manifested by intermittent hyperbilirubinemia, no changes in the structure of the liver, no hemolysis, Rh-conflict as well as cholestasis being noted. These jaundices include Crigler-Najjar syndrome type I, Crigler-Najjar syndrome type II and Gilbert's syndrome. They are characterized by an autosomal recessive inheritance due to the presence of mutations and polymorphisms in uridine 5'-diphosphate-glucuronosyltransferase gene (UGT1A1) leading to a decrease of the enzyme activity or to its complete loss. Objective. To demonstrate the peculiarities of diagnosis and treatment of a rare case of hereditary unconjugated hyperbilirubinemia - a combination of Crigler-Najjar syndrome type II and Gilbert's syndrome. Material and methods. Clinical observation of a patient G. aged 19, who was examined and treated at the Department of gastroenterology of a multidisciplinary hospital in Moscow in January 2021. Results. The patient G. has had icteric sclerae and skin since birth; he occasionally suffers from easy fatigability and general malaise. Physical examination revealed no changes (except for icteric discoloration). An increase in unconjugated bilirubin up to 270 μmol/L (median - 170 μmol/L) was detected. The molecular genetic study of UGT1A1 gene identified mutations in exon 4 Val378Asp (2002) and Arg108Cys as well as polymorphism 6/7TA in the promoter region, confirming the diagnosis of autosomal recessive inherited disease – a combination of Crigler Najjar syndrome type II and Gilbert's syndrome (heterozygous state), complicated by the development of hepatic encephalopathy stage 2. There was noted a significant decrease in unconjugated bilirubin up to 170.5 μmol/L, as well as improvement in general condition – reduced fatigue and weakness during the treatment with microsomal enzyme inducer (phenobarbital) and hyperammonemia corrector (ornithine aspartate). Conclusions. The use of molecular genetic analysis allows tailoring strategies for patient-specific disease diagnostics, treatment and prevention. The preservation of quality of life within satisfactory level is achieved through elimination of adverse effects provoking the development of this syndrome and through control of risk factors.
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Sagili, H., N. Pramya, D. Jayalaksmi y R. Rani. "Crigler–Najjar syndrome II and pregnancy outcome". Journal of Obstetrics and Gynaecology 32, n.º 2 (febrero de 2012): 188–89. http://dx.doi.org/10.3109/01443615.2011.636158.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Silva, E. Santos, R. Reding, J. de Ville, J. P. Buts, J. B. Otta y E. M. Sokal. "105 LIVER TRANSPLANTATION FOR CRIGLER NAJJAR SYNDROME". Journal of Pediatric Gastroenterology and Nutrition 20, n.º 4 (mayo de 1995): 471. http://dx.doi.org/10.1097/00005176-199505000-00115.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Arora, N. y S. Choudhary. "Pregnancy with Crigler–Najjar syndrome type II". Journal of Obstetrics and Gynaecology 29, n.º 3 (enero de 2009): 242–44. http://dx.doi.org/10.1080/01443610802706043.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

TAYLOR, W. G., S. A. WALKINSHAW, R. G. FARQUHARSON, R. A. FISKEN y I. T. GILMORE. "Pregnancy in Crigler-Najjar syndrome. Case report". BJOG: An International Journal of Obstetrics and Gynaecology 98, n.º 12 (diciembre de 1991): 1290–91. http://dx.doi.org/10.1111/j.1471-0528.1991.tb15405.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Jansen, P. L. M. "Diagnosis and management of Crigler-Najjar syndrome". European Journal of Pediatrics 158, S2 (1 de enero de 1999): S089—S094. http://dx.doi.org/10.1007/pl00014330.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Robards, Christopher y Sorin J. Brull. "The Anesthetic Implications of Crigler-Najjar Syndrome". Anesthesia & Analgesia 104, n.º 2 (febrero de 2007): 435–36. http://dx.doi.org/10.1213/01.ane.0000252462.70451.0e.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Lodoso Torrecilla, B., E. Palomo Atance, C. Camarena Grande, M. ªC Díaz Fernández, L. Hierro Llanillo, A. de la Vega Bueno, E. Frauca Remacha, G. Muñoz Bartolo y P. Jara Vega. "Síndrome de Crigler-Najjar: diagnóstico y tratamiento". Anales de Pediatría 65, n.º 1 (julio de 2006): 73–78. http://dx.doi.org/10.1157/13090900.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

O'Reilly, C. y R. Dixon. "Crigler-Najjar Syndrome: Treatment at Home with Phototherapy". Scottish Medical Journal 33, n.º 5 (octubre de 1988): 335–36. http://dx.doi.org/10.1177/003693308803300509.

Texto completo
Resumen
An infant became jaundiced in the neonatal period. The serum bilirubin failed to fall with phototherapy. A diagnosis of Crigler Najjar type 1 syndrome was made by exclusion and confirmed by liver biopsy. The infant has been successfully treated at home with phototherapy. Liver transplantation remains a therapeutic option.
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Sinha, R., S. Dalal y K. Sodhi. "Differentiating Gilbert Syndrome from Crigler Najjar Syndrome Type 2 by Phenobarbitone Test". Journal of Nepal Paediatric Society 35, n.º 1 (8 de octubre de 2015): 82–84. http://dx.doi.org/10.3126/jnps.v35i1.10620.

Texto completo
Resumen
Gilbert syndrome characterized by jaundice with intermittent elevations of indirect bilirubin, in the absence of haemolysis or underlying liver disease, has both autosomal dominant and recessive inheritance. Crigler-Najjar syndrome type II (CNS2) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). We report 20 children between age 5 to 15 years with unconjugated hyperbilirubenemia who were given seven days of oral phenobarbitone (5mg/kg/day) and decrease in level of bilirubin was noted. There was only 30-40% reduction of bilirubin in Crigler Najjar Syndrome Type 2 compared to Gilberts Syndrome in which bilirubin level normalised. This case series highlights the importance of simple test to differentiate these two conditions. This test is also very helpful in a place where enzyme level and mutational study cannot be done.J Nepal Paediatr Soc 2015;35(1):82-84
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Naher, Bodhrun, Md Wahiduzzaman Mazumder, Sharmistha Ghosal, Bodhrun Naher, AZM Raihanur Rahman y ASM Bazlul Karim. "Crigler Najjar Syndrome - A Rare case of Jaundice in Children". Northern International Medical College Journal 12, n.º 1 (13 de septiembre de 2022): 515–17. http://dx.doi.org/10.3329/nimcj.v12i1.61594.

Texto completo
Resumen
Crigler-Najjar syndrome (CNS) was first described in 1952 in Maryland, USA as congenital familial non-hemolytic jaundice with kernicterus by Crigler JF and Najjar VA.1 CNS is a rare genetic disorder characterized by abnormalities in bilirubin metabolism and evident by persistent increase of unconjugated bilirubin. During the first days of life, the syndrome clinically manifests as intense unconjugated hyperbilirubinemia without evidence of hemolysis. It consists of two types, type I and type II. Crigler-Najjar Syndrome is mostly autosomal recessive disorder, but variation may occur in the inheritance of CNS II.2 The key pathogenesis is defect in bilirubin conjugation due to complete or partial deficiency of uridine 5'-diphosphate-glucuronosyl transferase (UGT). This enzyme is required for the conjugation and further excretion of bilirubin from the body. In type I CNS the enzyme activity is completely absent and in type II there is partial absence of the enzyme. Therefore, Type I is more severe form and usually fatal with kernicterus at the age of 1-2 years.3-5 TypeII is less severe and has better prognosis. Patients with CN type II suffer from less jaundice, less neurological impairment, and show a fair response to phenobarbitone therapy (serum bilirubin levels decrease by at least 25%).6 Both males and females are equally affected by CNS. The incidence is approximately 1 in 750,000-1,000,000 in the general population.7 Here we report such a rare case. Northern International Medical College Journal Vol. 12 No.1 July 2020, Page 515-517
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Razek, Ahmed Abdel Khalek Abdel, Mohamed Ezz El Regal, Mortada El-Shabrawi, Mohamed Moustafa Abdeltawwab, Ahmed Megahed, Sherine Elzeny, Noha El Tantawi y Saher Ebrahiem Taman. "Diffusion Tensor Imaging of Auditory Pathway in Patients With Crigler-Najjar Syndrome Type I: Correlation With Auditory Brainstem Response". Journal of Child Neurology 37, n.º 2 (27 de diciembre de 2021): 119–26. http://dx.doi.org/10.1177/08830738211025865.

Texto completo
Resumen
Aim: To evaluate the role of diffusion tensor imaging of the auditory pathway in patients with Crigler Najjar syndrome type I and its relation to auditory brainstem response. Methods: Prospective study was done including 12 patients with Crigler Najjar syndrome type I and 10 age- and sex-matched controls that underwent diffusion tensor imaging of brain. Mean diffusivity and fractional anisotropy at 4 regions of the brain and brainstem on each side were measured and correlated with the results of auditory brainstem response for patients. Results: There was significantly higher mean diffusivity of cochlear nucleus, superior olivary nucleus, inferior colliculus, and auditory cortex of patients versus controls on both sides for all regions ( P = .001). The fractional anisotropy of cochlear nucleus, superior olivary nucleus, inferior colliculus, and auditory cortex of patients versus controls was significantly lower, with P values of, respectively, .001, .001, .003, and .001 on the right side and .001, .001, .003, and .001 on left side, respectively. Also, a negative correlation was found between the maximum bilirubin level and fractional anisotropy of the left superior olivary nucleus and inferior colliculus of both sides. A positive correlation was found between the mean diffusivity and auditory brainstem response wave latency of the right inferior colliculus and left cochlear nucleus. The fractional anisotropy and auditory brainstem response wave latency of the right superior olivary nucleus, left cochlear nucleus, and inferior colliculus of both sides were negatively correlated. Conclusion: Diffusion tensor imaging can detect microstructural changes in the auditory pathway in Crigler Najjar syndrome type I that can be correlated with auditory brainstem response.
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Maruo, Yoshihiro, Mahdiyeh Behnam, Shinichi Ikushiro, Sayuri Nakahara, Narges Nouri y Mansour Salehi. "Two Different UGT1A1 Mutations causing Crigler–Najjar Syndrome types I and II in an Iranian Family". Journal of Gastrointestinal and Liver Diseases 24, n.º 4 (1 de diciembre de 2015): 523–26. http://dx.doi.org/10.15403/jgld.2014.1121.244.ugt.

Texto completo
Resumen
Background: Crigler–Najjar syndrome type I (CN-1) and type II (CN-2) are rare hereditary unconjugated hyperbilirubinemia disorders. However, there have been no reports regarding the co-existence of CN-1 and CN-2 in one family. We experienced a case of an Iranian family that included members with either CN-1 or CN-2. Genetic analysis revealed a mutation in the bilirubin UDP-glucuronosyltransferase (UGT1A1) gene that resulted in residual enzymatic activity.Case report: The female proband developed severe hyperbilirubinemia [total serum bilirubin concentration (TB) = 34.8 mg/dL] with bilirubin encephalopathy (kernicterus) and died after liver transplantation. Her family history included a cousin with kernicterus (TB = 30.0 mg/dL) diagnosed as CN-1. Her great grandfather (TB unknown) and uncle (TB = 23.0 mg/dL) developed jaundice, but without any treatment, they remained healthy as CN-2. Results: The affected cousin was homozygous for a novel frameshift mutation (c.381insGG, p.C127WfsX23). The affected uncle was compound heterozygous for p.C127WfsX23 and p.V225G linked with A(TA)7TAA. p.V225G-UGT1A1 reduced glucuronidation activity to 60% of wild-type. Thus, linkage of A(TA)7TAA and p.V225G might reduce UGT1A1 activity to 18%–36 % of the wild-type. Conclusion: Genetic and in vitro expression analyses are useful for accurate genetic counseling for a family with a history of both CN-1 and CN-2. Abbreviations: CN-1: Crigler–Najjar syndrome type I; CN-2: Crigler–Najjar syndrome type II; GS: Gilbert syndrome; UGT1A1: bilirubin UDP-glucuronosyltransferase; WT: Wild type; TB: total serum bilirubin.
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Nampoothiri, Sheela, KarippothMohandas Nair y Peter Lohse. "Crigler-Najjar syndrome type 2: Novel UGT1A1 mutation". Indian Journal of Human Genetics 18, n.º 2 (2012): 233. http://dx.doi.org/10.4103/0971-6866.100776.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

HANSEN, THOR WILLY RUUD. "More to Be Learned From Crigler-Najjar Patients". Pediatrics 92, n.º 1 (1 de julio de 1993): 184. http://dx.doi.org/10.1542/peds.92.1.184.

Texto completo
Resumen
To the Editor.— In a recent study by Galbraith et al,1 the use of tin-mesoporphyrin in two patients with the Crigler-Najjar type I syndrome is described. The feasibility of this kind of treatment is documented, and the authors' comments on the size of the total-body bilirubin pool as well as their calculations on bilirubin production and clearance in these patients are illuminating. Personally, I am intrigued as much by aspects of the case reports, about which the authors do not comment, probably because these aspects are outside the focus of their paper.
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

GALBRAITH, RICHARD A., GEORGE S. DRUMMOND y ATTALLAH KAPPAS. "More to Be Learned From Crigler-Najjar Patients". Pediatrics 92, n.º 1 (1 de julio de 1993): 184–85. http://dx.doi.org/10.1542/peds.92.1.184a.

Texto completo
Resumen
In Reply.— We thank Dr Hansen for his comments on our study in Crigler-Najjar patients published recently in Pediatrics. A collaborative study of this rare genetic disease does seem in order as Dr Hansen indicates; to the extent that such a study might involve an examination of the efficacy of the heme oxygenase inhibitor tin-mesaporphyrin for ameliorating (with other therapeutic modalities) hyperbilirubinemia in this syndrome, we would be happy to collaborate with other investigators and to provide some resources for the study as required.
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

HANSEN, THOR WILLY RUUD. "More to be Learned from Crigler-Najjar Patients". Pediatrics 89, n.º 6 (1 de junio de 1992): 1268–69. http://dx.doi.org/10.1542/peds.89.6.1268b.

Texto completo
Resumen
To the Editor.— In a recent study by Galbraith et al,1the use of tin-mesopor-phyrin in two patients with the Crigler-Najjar type I syndrome is described. The feasibility of this kind of treatment is documented, and their comments on the size of the total-body bilirubin pool as well as their calculations on bilirubin production and clearance in these patients are very interesting and illuminating. However, I am personally as much intrigued by aspects of the case reports, about which the authors do not comment, probably because it is outside the focus of their paper.
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Millichap, J. Gordon. "Cerebellar Symptoms in Crigler-Najjar Type I Disease". Pediatric Neurology Briefs 6, n.º 7 (1 de julio de 1992): 56. http://dx.doi.org/10.15844/pedneurbriefs-6-7-12.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Mitchell, Ellen, Sarangarajan Ranganathan, Patrick McKiernan, Robert H. Squires, Kevin Strauss, Kyle Soltys, George Mazariegos y James E. Squires. "Hepatic Parenchymal Injury in Crigler-Najjar Type I". Journal of Pediatric Gastroenterology and Nutrition 66, n.º 4 (abril de 2018): 588–94. http://dx.doi.org/10.1097/mpg.0000000000001843.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Prager, Marie Csete, Kristen L. Johnson, Nancy L. Ascher y John P. Roberts. "Anesthetic Care of Patients With Crigler-Najjar Syndrome". Anesthesia & Analgesia 74, n.º 1 (enero de 1992): 162???164. http://dx.doi.org/10.1213/00000539-199201000-00031.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Hassona, Yazan, Ala'a Al Haddad y Ala'a Atef. "Oral findings in Crigler‐Najjar syndrome type I". Special Care in Dentistry 40, n.º 6 (3 de septiembre de 2020): 611–12. http://dx.doi.org/10.1111/scd.12518.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Shevell, Michael I., Annette Majnemer y David Schiff. "Neurologic Perspectives of Crigler-Najjar Syndrome Type I". Journal of Child Neurology 13, n.º 6 (junio de 1998): 265–69. http://dx.doi.org/10.1177/088307389801300605.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

YOUNG, TON-HO, YOU-CHEN CHAO, HUNG-SHUNG TANG y WEN-SHENG HUANG. "Hepatobiliary Imaging in Crigler-Najjar Syndrome Type 2". Clinical Nuclear Medicine 23, n.º 11 (noviembre de 1998): 780–81. http://dx.doi.org/10.1097/00003072-199811000-00017.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

MORI, TADASHI. "A case of II type Crigler-Najjar syndrome." Nihon Naika Gakkai Zasshi 80, n.º 1 (1991): 102–3. http://dx.doi.org/10.2169/naika.80.102.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Nydegger, Andy, Andrew Bednarz y Winita Hardikar. "Use of daytime phototherapy for Crigler-Najjar disease". Journal of Paediatrics and Child Health 41, n.º 7 (julio de 2005): 387–89. http://dx.doi.org/10.1111/j.1440-1754.2005.00642.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Kagita, Atsushi, Yukihiko Adachi, Akira Kambe, Toshinori Kamisako y Toshio Yamamoto. "Type II Crigler-Najjar syndrome with intrahepatic cholestasis". Journal of Gastroenterology 29, n.º 2 (marzo de 1994): 214–17. http://dx.doi.org/10.1007/bf02358686.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Ambrosino, Giovanni, Sergio Varotto, Stephen C. Strom, Graziella Guariso, Elisa Franchin, Diego Miotto, Luciana Caenazzo et al. "Isolated Hepatocyte Transplantation for Crigler-Najjar Syndrome Type 1". Cell Transplantation 14, n.º 2-3 (febrero de 2005): 151–57. http://dx.doi.org/10.3727/000000005783983250.

Texto completo
Resumen
Crigler-Najjar syndrome type 1 (CN1) is an inherited disorder characterized by the absence of hepatic uridine diphosphoglucuronate glucuronosyltransferase (UDPGT), the enzyme responsible for the conjugation and excretion of bilirubin. We performed allogenic hepatocyte transplantation (AHT) in a child with CN1, aiming to improve bilirubin glucuronidation in this condition. A 9-year-old boy with CN1 was prepared with plasmapheresis and immunosuppression with prednisolone and tacrolimus. When a graft was made available, 7.5 × 109 hepatocytes were isolated and infused into the portal vein percutaneously. After 2 weeks phenobarbitone was added to promote the enzymatic activity of UDPGT of the transplanted hepatocytes. Nocturnal phototherapy was continued throughout the studied period. Total bilirubin was considered a reliable marker of allogenic cell function. There was no significant variation of vital signs nor complications during the infusion. Mean ± SD bilirubin level was 530 ± 38 μmol/L before and 359 ± 46 μmol/L after AHT (t-test, p < 0.001). However, the introduction of phenobarbitone was followed by a drop of tacrolimus level with increase of alanine aminotransferase (ALT) and increase of bilirubin. After standard treatment of cellular rejection bilirubin fell again but from then on it was maintained at a greater level. After discharge the patient experienced a further increase of bilirubin that returned to predischarge levels after readmission to the hospital. This was interpreted as poor compliance with phototherapy. Only partial correction of clinical jaundice and the poor tolerability to nocturnal phototherapy led the parents to refuse further hepatocyte infusions and request an orthotopic liver transplant. After 24 months the child is well, with good liver function on tacrolimus and prednisolone-based immunosuppression. Isolated AHT, though effective and safe, is not sufficient to correct CN1. Maintenance of adequate immunosuppression and family compliance are the main factors hampering the success of this procedure.
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Chaubal, Alisha Nitin, Ruchir Patel, Dhaval Choksi, Kaivan Shah, Meghraj Ingle y Prabha Sawant. "Management of pregnancy in Crigler Najjar syndrome type 2". World Journal of Hepatology 8, n.º 11 (2016): 530. http://dx.doi.org/10.4254/wjh.v8.i11.530.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Raposo, Filipa, Margarida Reis Morais, Marina Pinheiro, Mariana Costa, Isabel Martinho, Sérgio Mendanha y Miguel Salgado. "Síndrome de Crigler-Najjar tipo 2 – um caso atípico". Scientia Medica 24, n.º 2 (24 de junio de 2014): 168. http://dx.doi.org/10.15448/1980-6108.2014.2.16572.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Montenegro Miranda, Paula y Piter Bosma. "Towards Liver-Directed Gene Therapy for Crigler-Najjar Syndrome". Current Gene Therapy 9, n.º 2 (1 de abril de 2009): 72–82. http://dx.doi.org/10.2174/156652309787909508.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Wolff, H., G. Otto y H. Giest. "LIVER TRANSPLANTATION IN CRIGLER-NAJJAR SYNDROME A Case Report". Transplantation 42, n.º 1 (julio de 1986): 84. http://dx.doi.org/10.1097/00007890-198607000-00018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Gridelli, B., A. Lucianetti, S. Gatti, M. Colledan, R. Benti, A. Bruno, L. N. Rossi y L. R. Fassati. "Orthotopic liver transplantation for Crigler-Najjar type I syndrome". Transplantation Proceedings 29, n.º 1-2 (febrero de 1997): 440–41. http://dx.doi.org/10.1016/s0041-1345(96)00179-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Tu, Zhen-Hua, De-Sheng Shang, Jin-Cai Jiang, Wu Zhang, Min Zhang, Wei-Lin Wang, Hai-Yan Lou y Shu-Sen Zheng. "Liver transplantation in Crigler-Najjar syndrome type I disease". Hepatobiliary & Pancreatic Diseases International 11, n.º 5 (octubre de 2012): 545–48. http://dx.doi.org/10.1016/s1499-3872(12)60222-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Perretti, A., G. Crispino, L. Marcantonio, S. Lenta, M. Caropreso, F. Manganelli, S. Scianguetta, R. Iorio, A. Iolascon y P. Vajro. "Clinical Utility of Electrophysiological Evaluation in Crigler-Najjar Syndrome". Neuropediatrics 38, n.º 4 (agosto de 2007): 173–78. http://dx.doi.org/10.1055/s-2007-991147.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Tabarki, Brahim, Monia Khalifa, Moncef Yacoub, Kalthoum Tlili y Ahmed S. Essoussi. "Cerebellar symptoms heralding bilirubin encephalopathy in crigler-najjar syndrome". Pediatric Neurology 27, n.º 3 (septiembre de 2002): 234–36. http://dx.doi.org/10.1016/s0887-8994(02)00425-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Labrune, P., A. Myara, C. Hennion, J. P. Gout, F. Trivin y M. Odievre. "Crigler-Najjar type II disease inheritance: A family study". Journal of Inherited Metabolic Disease 12, n.º 3 (septiembre de 1989): 302–6. http://dx.doi.org/10.1007/bf01799221.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía